Autoimmune Complications of Chronic Lymphocytic Leukemia
Section snippets
Clinical Features
Autoimmunity in CLL is overwhelmingly AIHA. This section is not a comprehensive description of this condition, which can be found in standard text books, but a reminder of clinical features that are all too often forgotten. Even though AIHA is so common in CLL the diagnosis is frequently missed. A direct antiglobulin test (DAT) should be part of the standard work-up of all patients with CLL, and it should be repeated whenever the patient becomes anemic and before each round of treatment.
The
Autoantibodies Produced by Tumor Cells
The simplest explanation for autoimmunity in CLL is that the tumor cells are manufacturing the autoantibody. The CLL cell does secrete immunoglobulin. Using a sensitive radioassay, Stevenson et al30 demonstrated secretion of small amounts of idiotypic IgM by CLL cells. The immunoglobulin secreted by CLL cells is often autoreactive. Stimulation by phorbol ester induced the CLL cells from 12 of 14 patients to secrete IgM that reacted with a variety of autoantigens, including the Fc portion of
Treatment
There are very few data addressing the problem of how to treat the autoimmune complications of CLL. In general, treatment has been the same as when the disease occurs spontaneously. However, some treatments are less appropriate and there is also the question of whether and how to treat the CLL itself. The possibility that the immunosuppression caused by the disease or its treatment has triggered the autoimmunity has to be weighed against the prospect that treating the disease will eliminate the
Conclusion
The autoimmune complications of CLL appear to be a feature of the failing immune system, and may well be chiefly attributed to the loss of regulatory T cells, which is made worse by most forms of treatment, especially when it involves the use of purine analogues. The particular pattern of autoimmunity, mainly involving the destruction of the formed elements of the blood, may be related to the ability of the CLL cell to act as an APC. Autoimmune complications are frequently severe and may be
References (144)
- et al.
Symptomatic and hemopathic hemolytic anaemia
Am J Med
(1955) - et al.
Leukemia and auto-immunization. Some possible relationships
Blood
(1959) - et al.
The anemia of leukemia
Am J Med
(1960) - et al.
Current conceptsLarge granular lymphocyte leukaemia
Blood Rev
(1999) - et al.
Pure red cell aplasiaAssociation with large granular lymphocytic leukaemia and the prognostic value of cytogenetic abnormalities
Blood
(1996) - et al.
Bullous pemphigoid in chronic lymphocytic leukemia with the demonstration of anti-basement membrane antibodies
Am J Med
(1974) Chronic lymphocytic leukemia—An accumulative disease of immunologically incompetent lymphocytes
Blood
(1967)- et al.
An enzyme-linked direct antiglobulin test for assessing erythrocyte bound immunoglobulins
J Immunol Methods
(1988) - et al.
Autoimmune hemolytic anemia in chronic lymphocytic leukemiaClinical, therapeutic, and prognostic features
Blood
(2000) - et al.
Chronic lymphocytic leukemis (CLL) cells secrete multispecific autoantibodies
J Autoimmune
(1988)
High incidence of serum monoclonal Igs detected by a sensitive immunoblotting technique in B-cell chronic lymphocytic leukemia
Blood
Monoclonal immunoglobulin rescued from a patient with chronic lymphocytic leukemia and AIHA
Blood
B-cell neoplasms with homogeneous cold-reacting antibodies (cold agglutinins)
Am J Med
Chronic lymphocytic leukemia preceded by cold agglutinin diseaseIntraclonal immunoglobulin light chain diversity in V(H)4-34 expressing single leukemic cells
Blood
C-1-inhibitor binding monoclonal immunoglobulins in three patients with acquired angioneurotic edema
J Allergy Clin Immunol
Severe AIHA in two patients treated with fludarabine for chronic lymphocytic leukemia
Ann Oncol
Fatal recurrence of autoimmune hemolytic anaemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anaemia
Ann Oncol
Lethal paraneoplastic pemphigus following treatment of chronic lymphocytic leukaemia with fludarabine
Ann Oncol
Association of oral pemphigus with chronic lymphocytic leukemia
Oral Surg Oral Med Oral Pathol
Paraneoplastic pemphigus appearing as a bullous pemphigoid eruption after palliative radiation therapy
J Am Acad Dermatol
Decreased CD45RA T cells in B-cell chronic lymphatic leukaemia patientsCorrelation with disease stage
Blood
Failure of B cells of chronic lymphocytic leukemia in presenting soluble and alloantigens
Clin Immunol Immunopathol
Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells
Blood
Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia
Blood
Autoimmune hemolytic anaemia
Semin Hematol
Red cell survival studies in normal and leukaemic subjects; latent haemolytic syndrome in leukaemia with splenomegaly—Nature of anaemia in leukaemia–Effect of splenomegaly
Acta Med Scand
Therapeutic considerations in chronic lymphocytic leukemia
Arch Intern Med
Die hämolytische Verlausform der chronischen lymphatischen Leukämie
Munch Med Woschenschr
Auto-immune hemolytic anemia in some malignant systemic diseases
Acta Med Scand
The chronic leukaemiasA review of disease manifestations and the aims of therapy
Can Med Assoc J
Hypogammaglobulinemia and disordered immunity in CLL
Autoimmunity in chronic lymphocytic leukaemia
J Clin Pathol
The blood platelets in the leukemias
Am J Med Sci
Immune reactions of platelets
Autoimmune thrombocytopenic purpura (“ITP type”) with chronic lymphocytic leukemia
Blood
Spectrum and frequency of autoimmune derangements in lymphoproliferative disordersAnalysis of 637 cases and comparison with myeloproliferative diseases
Br J Haematol
Leukaemia of large granular lymphocytesassociation with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anaemia
Ann Intern Med
Evidence for involvement of activated CD8+/HLA-DR+ cells in the pathogenesis of neutropenia in patients with B-cell chronic lymphocytic leukaemia
Eur J Haematol
Pure red cell aplasia in patients with chronic lymphocytic leukaemia
Medicine (Baltimore)
Autoimmune disease and chronic lymphocytic leukaemiaAutoimmune hemolytic anaemia, pure red cell aplasia and autoimmune thrombocytopenia
Semin Hematol
Leukemias and autoimmune diseasesSjøgren’s syndrome and hemolytic anemia associated with chronic lymphocytic anemia
Can Med Assoc J
Nephtotic syndrome in chronic lymphocytic leukaemia
Br Med J
Autoimmune hyperthyroidism and thrombocytopenia in a patient with chronic lymphocytic leukemia
Am J Hematol
Patterns of immunological deficiency in lymphomas and leukemias
Ann Intern Med
Extracellular idiotypic immunoglobulin arising from human leukaemia B lymphocytes
J Exp Med
Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia
J Exp Med
Expression of Ly-1 by a subset of B lymphocytes
J Immunol
The Ly-1 B cell subpopulation in normal, immunodefective and autoimmune mice
J Exp Med
The Ly1-B cell lineage
Immunol Rev
Peritoneal Ly1-B cellsGenetic control, autoantibody production, increased lambda light chain expression
Euro J Immunol
Cited by (166)
Lymphoid Leukemias
2022, Clinical Immunology: Principles and Practice, Sixth EditionPonatinib-associated panniculitis: Case report and review of the literature
2021, Cancer Treatment and Research CommunicationsSecondary ITP in adults
2021, Revue de Medecine InterneThe prevalence and prognostic significance of autoimmune cytopenias in a cohort of Egyptian patients with chronic lymphocytic leukemia
2019, Hematology/ Oncology and Stem Cell TherapyChronic Lymphocytic Leukemia
2019, Abeloff’s Clinical Oncology